146
Participants
Start Date
March 29, 2013
Primary Completion Date
September 26, 2016
Study Completion Date
September 26, 2016
BKM120
BKM120 100 mg (oral gelatine capsules) was administered orally once daily starting from cycle 1 day 1 and will be dosed continuously every day for each 28-day cycle
New York Oncology Hematology NY Onc Hem, Albany
West Penn Allegheny Oncology Network, Natrona Heights
University of Pittsburgh Medical Center UPMC, Pittsburgh
Gettysburg Cancer Center, Gettysburg
Abington Hematology Oncology Associates, Inc Abington Hem Onc Assoc (5), Willow Grove
Virginia Cancer Specialists Virginia Cancer Specialists, Fairfax
Blue Ridge Research Center at Roanoke Neurological Center McKesson Specialty Care, Roanoke
Waverly Hematology Oncology, Cary
Duke University Medical Center Seeley G. Mudd Bldg., Durham
Southeastern Regional Medical Center, Newnan
University Cancer & Blood Center, LLC, Athens
Florida Hospital Cancer Institute FL Hosp. Cancer Instit., Orlando
Florida Cancer Specialists, West Palm Beach
Florida Cancer Specialists Dept of Oncology (2), Fort Myers
Sarah Cannon Research Institute, Nashville
Chattanooga Oncology and Hematology Assoicates, PC Chattanooga Oncology, Chattanooga
West Cancer Clinic, Memphis
Mid Ohio Oncology/Hematology Mark H. Zangmeister Center, Columbus
Cleveland Clinic Foundation Cleveland Clinic (19), Cleveland
Northern Indiana Cancer Research Consortium No. Indiana Cancer Res., South Bend
Cancer and Hematology Centers of West Michigan Dept. of Oncology, Grand Rapids
University of Iowa Hospitals & Clinics Regulatory Contact 2, Iowa City
Medical College of Wisconsin Cancer Center, Milwaukee
Minnesota Oncology Hematology, P.A. Minnesota Oncology Hematology, Minneapolis
Sanford University of South Dakota Medical Center Sanford Health, Sioux Falls
Cancer Treatment Centers of America Southwestern Regional Med. Ctr, Schaumburg
Lurie Children's Hospital of Chicago Developmental Therapeutics, Chicago
Cancer Care Specialists of Central Illinois, Decatur
Nebraska Cancer Specialists Oncology Hematology West, Omaha
Highlands Oncology Group, Fayetteville
Texas Oncology P A Round Rock, Dallas
Tyler Cancer Center, Tyler
Texas Oncology, P.A. Texas Oncololgy, P.A. (8), Fort Worth
Oncology Consultants Oncology Group, Houston
MD Anderson Cancer Center/University of Texas MD Anderson Cancer Center (3), Houston
Cancer Care Centers of South Texas HOAST CCC of So. TX-San Antonio (3), San Antonio
Texas Oncology Sammons Cancer Center Sammons Cancer Center (10), Dallas
Intermountain Medical Center Intermountain Healthcare, Murray
Arizona Oncology Associates PC- HAL, Sedona
Comprehensive Cancer Centers, Las Vegas
Sarcoma Oncology Center, Santa Monica
Northwest Cancer Specialists Compass Oncology (36), Portland
Oregon Health and Science University Oregon Health & Science U (56), Portland
Salem Health, Salem
Bend Memorial Clinic Bend Mem. Clinic, Bend
Northwest Medical Specialties Hematology/Oncology, Tacoma
Kadlec Clinic Hematology and Oncology Kadlec Clinic Hematology & Onc, Kennewick
Arizona Oncology Associates HOPE Division, Phoenix
Rocky Mountain Cancer Centers RMCC - Aurora, Greenwood Village
Cancer Center at Presbyterian, Albuquerque
Whittingham Cancer Center Norwalk Hospital, Norwalk
Eastern Connecticut Hematology & Oncology Associates The Norwich Cancer Center, Norwich
Illinois Cancer Care P.C. IL. Cancer Care, Peoria
Illinois Cancer Care P.C., Peoria
Eastern Maine Medical Center Research Center SC, Bangor
Mount Auburn Hospital, Cambridge
Michigan Medicine University of Michigan Int. Medicine Oncology, Ann Arbor
Hematology Oncology Associates of Northern New Jersey PA Regional Cancer Care Assoc., Morristown
University of N C at Chapel Hill Physician Office Building, Chapel Hill
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY